The HydraTek® Process
Why all amniotic & placental tissues are not equal.
Amniotic membrane tissues have been used clinically throughout the 20th century to successfully treat various chronic and acute wounds. Over the last decade tissue banks have made a variety of amniotic membrane-based allografts commercially available in the U.S. Most of these processors have focused on creating limited product forms using only the basic amniotic membranes available from the placenta.
The HydraTek® Process has made numerous advancements in the field of placental processing, maximizing the rich natural potential that the entire placenta has to offer. HydraTek® is designed to preserve like no other commercial system all of the key tissues available for transplant from the placenta, preserve them in their most natural form, and deliver the ultimate range of allograft forms.
While various tissue processors may use a similar donated placental tissue source, the resulting quality and performance of a human tissue allograft varies greatly depending on the processing methods that it undergoes.
The HydraTek® Process uses new revolutionary technology and sophisticated processing methods to capitalize so the full potential of the placenta can be utilized like no other company, preserving function and integrity in their natural hydrated state while allowing for improved handling and delivery methods. The HydraTek® Process has proven quality, providing the utmost in patient safety and allograft preservation.
HydraTek® Process has proven safety and quality, surpassing FDA and AATB standards to provide the utmost in patient safety and preservation of native placental tissue allografts transplants.